DE69901379D1 - Camptothecin-Derivate mit Antitumor-Wirkung - Google Patents

Camptothecin-Derivate mit Antitumor-Wirkung

Info

Publication number
DE69901379D1
DE69901379D1 DE69901379T DE69901379T DE69901379D1 DE 69901379 D1 DE69901379 D1 DE 69901379D1 DE 69901379 T DE69901379 T DE 69901379T DE 69901379 T DE69901379 T DE 69901379T DE 69901379 D1 DE69901379 D1 DE 69901379D1
Authority
DE
Germany
Prior art keywords
tumor effects
camptothecin derivatives
camptothecin
derivatives
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69901379T
Other languages
English (en)
Other versions
DE69901379T2 (de
Inventor
Sergio Penco
Lucio Merlini
Paolo C O Sigma-Tau Carminati
Franco C O Sigma-Tau In Zunino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto Nazionale per lo Studio e la Cura die Tumori
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Istituto Nazionale per lo Studio e la Cura die Tumori
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto Nazionale per lo Studio e la Cura die Tumori, Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Istituto Nazionale per lo Studio e la Cura die Tumori
Application granted granted Critical
Publication of DE69901379D1 publication Critical patent/DE69901379D1/de
Publication of DE69901379T2 publication Critical patent/DE69901379T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69901379T 1999-03-09 1999-03-09 Camptothecin-Derivate mit Antitumor-Wirkung Expired - Lifetime DE69901379T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99830124A EP1044977B1 (de) 1999-03-09 1999-03-09 Camptothecin-Derivate mit Antitumor-Wirkung

Publications (2)

Publication Number Publication Date
DE69901379D1 true DE69901379D1 (de) 2002-06-06
DE69901379T2 DE69901379T2 (de) 2002-11-07

Family

ID=8243303

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69901379T Expired - Lifetime DE69901379T2 (de) 1999-03-09 1999-03-09 Camptothecin-Derivate mit Antitumor-Wirkung

Country Status (39)

Country Link
US (2) US6242457B1 (de)
EP (1) EP1044977B1 (de)
JP (1) JP4610743B2 (de)
KR (1) KR100702085B1 (de)
CN (1) CN1139592C (de)
AR (1) AR022860A1 (de)
AT (1) ATE216998T1 (de)
AU (1) AU774174B2 (de)
BG (1) BG65032B1 (de)
BR (1) BR0008840B1 (de)
CA (1) CA2362760C (de)
CO (1) CO5180590A1 (de)
CZ (1) CZ304465B6 (de)
DE (1) DE69901379T2 (de)
DK (1) DK1044977T3 (de)
EA (1) EA003605B1 (de)
EE (1) EE04679B1 (de)
EG (1) EG23999A (de)
ES (1) ES2175919T3 (de)
HK (1) HK1031222A1 (de)
HR (1) HRP20010667B1 (de)
HU (1) HU229506B1 (de)
IL (2) IL144958A0 (de)
IS (1) IS2003B (de)
ME (2) ME00017B (de)
MX (1) MXPA01009081A (de)
NO (1) NO328363B1 (de)
NZ (1) NZ513393A (de)
PE (1) PE20001485A1 (de)
PL (1) PL222208B1 (de)
PT (1) PT1044977E (de)
RS (1) RS50405B (de)
SI (1) SI1044977T1 (de)
SK (1) SK287561B6 (de)
TN (1) TNSN00045A1 (de)
TR (1) TR200102603T2 (de)
TW (1) TWI272272B (de)
WO (1) WO2000053607A1 (de)
ZA (1) ZA200107408B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60036915T2 (de) 1999-01-13 2008-08-07 Alchemia Oncology Pty Ltd., Hawthorn Verwendung von hyaluronan zur herstellung eines medikaments zur erhöhung der wirksamkeit von zytotoxischen arzneimitteln
US7105492B2 (en) 1999-03-09 2006-09-12 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Camptothecin derivatives having antitumor activity
FR2794123B1 (fr) * 1999-05-28 2001-07-27 Aventis Pharma Sa Preparation de derives de la camptothecine et de la nothapodytine
US6352996B1 (en) * 1999-08-03 2002-03-05 The Stehlin Foundation For Cancer Research Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
AUPQ879500A0 (en) * 2000-07-14 2000-08-10 Meditech Research Limited Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
US9066919B2 (en) * 2000-07-14 2015-06-30 Alchemia Oncology Pty Limited Hyaluronan as a chemo-sensitizer in the treatment of cancer
US20040029906A1 (en) * 2001-07-31 2004-02-12 Michael Christman Inhibitors of dna polymerase sigma
MXPA04001828A (es) * 2001-08-27 2005-03-07 Meditech Res Ltd Protocolos terapeuticos mejorados.
WO2003033525A1 (en) * 2001-10-12 2003-04-24 Debio Recherche Pharmacuetique S.A. Amino-substituted camptothecin polymer derivatives and use of the same for the manufacture of a medicament
ITRM20020305A1 (it) * 2002-05-31 2003-12-01 Sigma Tau Ind Farmaceuti Camptotecine con anello lattonico modificato.
ITRM20020306A1 (it) 2002-05-31 2003-12-01 Sigma Tau Ind Farmaceuti Esteri in posizione 20 di camptotecine.
FR2852606A1 (fr) * 2003-03-18 2004-09-24 Inst Nat Sante Rech Med Moyens pour inhiber simultanement l'expression de plusieurs genes impliques dans une pathologie
US20040204435A1 (en) * 2003-04-09 2004-10-14 Joachim Liehr Alternating treatment with topoisomerase I and topoisomerase II inhibitors
ITRM20030344A1 (it) * 2003-07-14 2005-01-15 Ist Naz Stud Cura Dei Tumori 7-n-poliamminoalchil(ossi)imminometilcamptotecine recanti gruppi protettivi.
WO2005092302A2 (en) * 2004-03-26 2005-10-06 Novartis Ag Use of camptothecin derivates for the treatment of proliferative diseases in a fixed dosing regimen
JP5170741B2 (ja) 2004-04-27 2013-03-27 ウェルスタット バイオロジクス コーポレイション ウイルスおよびカンプトテシン類を使用する癌の処置
ITRM20040242A1 (it) * 2004-05-13 2004-08-13 Ist Naz Stud Cura Dei Tumori "7-t-butossiimminometilcamptotecina coniugata in posizione 20 con antagonisti delle integrine.
ITRM20040240A1 (it) * 2004-05-13 2004-08-13 Ist Naz Stud Cura Dei Tumori Camptotecine coniugate in posizione 7 con antagonisti delle integrine.
ITRM20040241A1 (it) * 2004-05-13 2004-08-13 Ist Naz Stud Cura Dei Tumori Camptotecine coniugate in posizione 20 con antagonisti delle integrine.
ITRM20040288A1 (it) * 2004-06-11 2004-09-11 Sigma Tau Ind Farmaceuti Uso della 7-t-butossiimminometilcamptotecina per la preparazione di un medicamento per il trattamento delle neoplasie dell'utero.
CN100334089C (zh) * 2004-07-21 2007-08-29 王洋 一种9－硝基喜树碱的生产方法
GT200500310A (es) * 2004-11-19 2006-06-19 Compuestos organicos
KR101367516B1 (ko) * 2004-12-15 2014-02-27 씨그마-토 인더스트리에 파마슈티체 리유니테 에스. 피. 에이. 암치료용 치료제의 조합물
AU2005318227B2 (en) 2004-12-21 2011-08-18 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Stereoselective process and crystalline forms of a camptothecin
SA06270147B1 (ar) 2005-06-09 2009-12-22 نوفارتيس ايه جي عملية لتخليق 5-(مثيل–1h–إيميدازول–1-يل )–3-(ثلاثي فلـورو مثيل)–بنزامـين
JP5190958B2 (ja) 2005-07-14 2013-04-24 ウェルスタット バイオロジクス コーポレイション ウイルス、フルオロピリミジンおよびカンプトテシンを使用した癌の処置
CA2616607C (en) * 2005-07-27 2015-06-02 Alchemia Oncology Pty Limited Therapeutic protocols using hyaluronan
ITRM20050418A1 (it) * 2005-08-04 2007-02-05 Sigma Tau Ind Farmaceuti Sistemi terapeutici a rilascio immediato per il migliorato assorbimento orale di 7-[(e)-t-butilossimminometil] camptotecina.
KR20080034149A (ko) * 2005-08-10 2008-04-18 노파르티스 아게 7-(ｔ-부톡시)이미노메틸 캄토테신에 대한 제형
CN101287475B (zh) * 2005-09-07 2012-11-14 阿尔卡米亚肿瘤学股份有限公司 包含透明质酸和治疗抗体的治疗组合物以及制药用途
RS52272B (en) * 2005-12-21 2012-10-31 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. TREATMENT OF TUMOR-RESISTANT TUMORS
CA2642717C (en) * 2006-02-17 2015-08-18 Novacea, Inc. Treatment of hyperproliferative diseases with vinca alkaloid n-oxide and analogs
JP5313867B2 (ja) 2006-03-30 2013-10-09 ドライス ファーマシューティカルズ，インコーポレイティド カンプトテシン−細胞透過性ペプチド複合体及びそれを含む医薬組成物
WO2008094959A1 (en) * 2007-02-01 2008-08-07 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Pharmaceutical composition comprising a campothecin derivative
US8853233B2 (en) * 2007-02-13 2014-10-07 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Broad-spectrum anti-cancer treatment based on iminocamptothecin derivatives
JP5765937B2 (ja) * 2007-08-01 2015-08-19 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニＳｉｇｍａ−Ｔａｕ Ｉｎｄｕｓｔｒｉｅ Ｆａｒｍａｃｅｕｔｉｃｈｅ Ｒｉｕｎｉｔｅ Ｓｏｃｉｅｔａ Ｐｅｒ Ａｚｉｏｎｉ 小児腫瘍の治療
EP2096113A1 (de) * 2008-02-05 2009-09-02 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. 9-substituierte Camptothecin-Derivate als Antitumorverbindungen
TWI482621B (zh) 2009-12-23 2015-05-01 Sigma Tau Ind Farmaceuti 青蒿素基藥物與其他化學治療劑的抗癌組合物
JP6877049B2 (ja) 2015-09-25 2021-05-26 ゼットワイ セラピューティクス インク．Ｚｙ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 多糖類−ビタミン共役体を含む粒状物に基づく薬物製剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399276A (en) * 1981-01-09 1983-08-16 Kabushiki Kaisha Yakult Honsha 7-Substituted camptothecin derivatives
CA2123321C (en) * 1991-11-15 2003-09-30 Randall Keith Johnson Combination chemotherapy
US5614529A (en) * 1994-09-22 1997-03-25 Research Triangle Institute Inhibition of plasmodia parasites by camptothecin compounds
US5972955A (en) * 1995-06-06 1999-10-26 Dr. Reddy's Research Foundation Water soluble C-ring analogues of 20(S)-camptothecin
GB9512670D0 (en) * 1995-06-21 1995-08-23 Sod Conseils Rech Applic Camptothecin analogues
IT1282673B1 (it) * 1996-02-23 1998-03-31 Ist Naz Stud Cura Dei Tumori Derivati della camptotecina e loro uso come agenti antitumorali
CA2262745C (en) * 1996-08-19 2006-04-04 Bionumerik Pharmaceuticals, Inc. Highly lipophilic camptothecin derivatives

Also Published As

Publication number Publication date
RS50405B (sr) 2009-12-31
CA2362760C (en) 2009-08-18
CN1343209A (zh) 2002-04-03
TNSN00045A1 (fr) 2005-11-10
MEP4008A (xx) 2010-02-10
BG65032B1 (bg) 2006-12-29
JP2002539128A (ja) 2002-11-19
TWI272272B (en) 2007-02-01
MXPA01009081A (es) 2002-08-30
EA003605B1 (ru) 2003-06-26
EE04679B1 (et) 2006-08-15
ME00017B (me) 2010-06-10
US20010008939A1 (en) 2001-07-19
US6242457B1 (en) 2001-06-05
IL144958A (en) 2009-08-03
EG23999A (en) 2008-03-19
BG105810A (en) 2002-06-28
CN1139592C (zh) 2004-02-25
EP1044977B1 (de) 2002-05-02
KR100702085B1 (ko) 2007-04-02
DE69901379T2 (de) 2002-11-07
NO20014128D0 (no) 2001-08-24
NO20014128L (no) 2001-08-24
NZ513393A (en) 2003-04-29
HUP0200210A3 (en) 2004-03-29
AU774174B2 (en) 2004-06-17
BR0008840B1 (pt) 2011-12-27
CZ304465B6 (cs) 2014-05-21
AU3160400A (en) 2000-09-28
CA2362760A1 (en) 2000-09-14
IS6031A (is) 2001-07-31
IS2003B (is) 2005-04-15
ATE216998T1 (de) 2002-05-15
NO328363B1 (no) 2010-02-01
PT1044977E (pt) 2002-09-30
DK1044977T3 (da) 2002-07-08
ZA200107408B (en) 2002-05-29
HU229506B1 (en) 2014-01-28
EP1044977A1 (de) 2000-10-18
US6589939B2 (en) 2003-07-08
SK11642001A3 (sk) 2002-01-07
HUP0200210A2 (hu) 2002-05-29
ES2175919T3 (es) 2002-11-16
SK287561B6 (sk) 2011-02-04
CZ20013077A3 (cs) 2002-01-16
IL144958A0 (en) 2002-06-30
PL222208B1 (pl) 2016-07-29
CO5180590A1 (es) 2002-07-30
HK1031222A1 (en) 2001-06-08
HRP20010667A2 (en) 2002-08-31
KR20010102519A (ko) 2001-11-15
JP4610743B2 (ja) 2011-01-12
YU64301A (sh) 2005-07-19
AR022860A1 (es) 2002-09-04
PL355094A1 (en) 2004-03-22
HRP20010667B1 (en) 2003-06-30
EE200100466A (et) 2002-12-16
PE20001485A1 (es) 2000-12-07
SI1044977T1 (en) 2002-08-31
WO2000053607A1 (en) 2000-09-14
EA200100954A1 (ru) 2002-04-25
BR0008840A (pt) 2002-01-08
TR200102603T2 (tr) 2002-01-21

Similar Documents

Publication Publication Date Title
DE69901379D1 (de) Camptothecin-Derivate mit Antitumor-Wirkung
ATE304352T1 (de) Indolyl-3-glyoxylsäure-derivate mit antitumorwirkung
IS5381A (is) 4-fenyl-pyridin afleiður
DE60009747D1 (de) Admantan-derivate
ATE293104T1 (de) Thiazolylamid-derivate
EE200100613A (et) 13-metüülerütromütsiini derivaadid
DK1187814T3 (da) 5-phenyl-pyrimidinderivater
ATE257148T1 (de) Propargyletherderivate
DK1240157T3 (da) Substituerede N-benzyl-indol-3-yl-glyoxylsyrederivater med antitumorvirkning
ATE374747T1 (de) Monofluoralkylderivate
ATE273272T1 (de) Mevinolinderivate
DK1218340T3 (da) 4-hydroxybiphenylhydrazid-derivater
ATE293592T1 (de) Resorcinderivate
DK1187815T3 (da) 4-phenyl-pyrimidinderivater
NO20005031D0 (no) Kinolin-4-yl-derivater II
NO20004892D0 (no) Kinolin-4-yl-derivater I
DK1088818T3 (da) Quinolin-4-yl-derivater
DE60025348D1 (de) Ethansulfonyl-piperidin-derivate
DE60001736T2 (de) 1-trifluorotmethyl-4-hydroxy-7-piperidinyl-aminomethylchroman-derivate
DE50015441D1 (de) Fadenliefergerät mit verstellbarer fadenleiteinrichtung
DE59909774D1 (de) 1-cycloalkylpyrazolyl-benzoyl-derivate
ATE259816T1 (de) Tricyclische benzoylcyclohexandion-derivate
ITMI992174A0 (it) Derivati benzopiranici

Legal Events

Date Code Title Description
8364 No opposition during term of opposition